Sartorius Aktiengesellschaft (FRA:SRT)

Market Cap	15.07B -3.0%
Revenue (ttm)	3.54B +4.7%
Net Income	154.90M +84.4%
EPS	2.24 +84.2%
Shares Out	n/a
PE Ratio	97.28
Forward PE	39.08
Dividend	0.73 (0.40%)
Ex-Dividend Date	Mar 27, 2026

Volume	20
Average Volume	20
Open	190.40
Previous Close	188.20
Day's Range	190.40 - 197.20
52-Week Range	138.20 - 207.00
Beta	n/a
RSI	59.74
Earnings Date	Feb 3, 2026

About FRA:SRT

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture...

• Industry: Laboratory Analytical Instruments
• Founded: 1870
• Employees: 13,671
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SRT

Financial Performance

In 2025, FRA:SRT's revenue was 3.54 billion, an increase of 4.66% compared to the previous year's 3.38 billion. Earnings were 154.90 million, an increase of 84.40%.